Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Inv. presentation
Quarterly results
|
|
Furiex Pharmaceuticals, Inc. (FURX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2014 |
4
| Forest Laboratories, LLC (10% Owner) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Bought 11,169,066 shares
@ $95, valued at
$1061.1M
Bought 11,169,066 shares
@ $95, valued at
$1061.1M
|
|
| 07/07/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/07/2014 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 07/07/2014 |
4
| COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 22,523 shares
@ $0
Disposed/sold 26,000 options to buy
@ $15, valued at
$390k
Disposed/sold 37,944 options to buy
@ $13.16, valued at
$499.3k
|
|
| 07/07/2014 |
4
| DIXON WENDY L (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 7,160 shares
@ $0
Disposed/sold 17,570 options to buy
@ $9.11, valued at
$160.1k
Disposed/sold 8,675 options to buy
@ $13.94, valued at
$120.9k
Disposed/sold 8,825 options to buy
@ $13.45, valued at
$118.7k
Disposed/sold 17,500 options to buy
@ $18.22, valued at
$318.9k
|
|
| 07/07/2014 |
4
| Patel Sailash (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 26,444 shares
@ $0
Disposed/sold 26,360 options to buy
@ $9.11, valued at
$240.1k
Disposed/sold 20,000 options to buy
@ $15, valued at
$300k
Disposed/sold 29,644 options to buy
@ $13.16, valued at
$390.1k
Disposed/sold 8,294 options to buy
@ $17.8, valued at
$147.6k
|
|
| 07/07/2014 |
4
| CORR PETER B (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 8,447 shares
@ $0
Disposed/sold 5,470 options to buy
@ $9.11, valued at
$49.8k
Disposed/sold 8,675 options to buy
@ $13.94, valued at
$120.9k
Disposed/sold 8,825 options to buy
@ $13.45, valued at
$118.7k
Disposed/sold 17,500 options to buy
@ $18.22, valued at
$318.9k
|
|
| 07/07/2014 |
4
| Almenoff June Sherie (President) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 07/07/2014 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 07/07/2014 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 9,308 shares
@ $0 |
|
| 06/26/2014 |
4
| Patel Sailash (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 32,928 shares
@ $104, valued at
$3.4M
Exercised 32,928 options to buy
@ $9.11, valued at
$300k
|
|
| 06/26/2014 |
4
| COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 10,368 shares
@ $104.12, valued at
$1.1M
Exercised 10,368 options to buy
@ $17.8, valued at
$184.6k
|
|
| 06/20/2014 |
4
| COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 45,691 shares
@ $104.11, valued at
$4.8M
Exercised 45,691 options to buy
@ $9.11, valued at
$416.2k
|
|
| 06/18/2014 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 06/17/2014 |
4
| COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 3,228 shares
@ $104.25, valued at
$336.5k
|
|
| 06/12/2014 |
4
| COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 2,872 shares
@ $104.63, valued at
$300.5k
|
|
| 06/12/2014 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 06/12/2014 |
4
| Patel Sailash (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 1,504 shares
@ $104.68, valued at
$157.4k
|
|
| 03/04/2014 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 03/04/2014 |
4
| Patel Sailash (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 03/04/2014 |
4
| Kaldor Stephen W (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 03/04/2014 |
4
| COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 13,500 shares
@ $0 |
|
| 03/04/2014 |
4
| CORR PETER B (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 3,580 shares
@ $0 |
|
| 03/04/2014 |
4
| DIXON WENDY L (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 3,580 shares
@ $0 |
|
| 03/04/2014 |
4
| DAVIS STEPHEN (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 3,580 shares
@ $0 |
|
| 02/06/2014 |
4
| Almenoff June Sherie (President) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 11/19/2013 |
4
| Patel Sailash (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 1,000 shares
@ $0 |
|
| 09/12/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/13/2013 |
4
| CORR PETER B (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Sold 7,500 shares
@ $39.74, valued at
$298.1k
Exercised 7,500 options to buy
@ $9.11, valued at
$68.3k
|
|
| 06/26/2013 |
4
| CORR PETER B (Director) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 887 shares
@ $33.1174, valued at
$29.4k
Paid exercise price by delivering 400 shares
@ $33.2983, valued at
$13.3k
Exercised 3,600 options to buy
@ $9.11, valued at
$32.8k
Exercised 1,000 options to buy
@ $9.11, valued at
$9.1k
|
|
| 06/12/2013 |
4
| Woodworth Marshall H (CFO) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 06/12/2013 |
4
| McIntyre Gail Frances (Senior Vice President-Research) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
| 06/12/2013 |
4
| COVINGTON PAUL S (Senior VP-Clinical Operations) has filed a Form 4 on Furiex Pharmaceuticals, Inc.|
Txns:
| Granted 12,200 shares
@ $0 |
|
| 06/12/2013 |
4
| Almenoff June Sherie (President) has filed a Form 4 on Furiex Pharmaceuticals, Inc. |
|
|
|